UPDATE
1-Otsuka loses lawsuit challenging FDA
approval of
generic Abilify
May 28 (Reuters) - Otsuka Pharmaceutical Co Ltd has lost a
lawsuit challenging the U.S. Food and Drug Administration's decision to allow
generic versions of the company's antipsychotic drug Abilify.
